Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho) profile picture

🇧🇷 Medical Oncologist

São Paulo, Brazil
Joined June 2022
Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)Photo by Cassio Murilo T. Hidalgo Filho (@CMHidalgoFilho)
Why do many patients with NSCLC stop benefiting from immunotherapy In our @JCO_ASCO review, we discussed the primary & acquired resistance to ICIs and emerging strategies to prevent, delay, and overcome it. ascopubs.org/doi/pdf/10.1200… @DanaFarber #NSCLC #LungCancer #Immunotherapy
2
13
43
3,048
Happy to be speaking in the LungO 2026 about the treatment of KRAS-mutant NSCLC. Thanks @oncodaily team for this opportunity.
Meet our LungÕ 2026 speaker: Cassio Murilo Hidalgo Filho! We’re delighted to welcome Dr. Cassio Murilo Hidalgo Filho (@CMHidalgoFilho), Medical Oncologist and Postdoctoral Fellow in Thoracic Oncology at Dana-Farber Cancer Institute, Harvard Medical School, USA, to LungÕ 2026 – Virtual Global Congress on Lung Oncology. Join us for a global exchange of ideas on advancing lung cancer care. 📅 November 5, 2026 🌐 Virtual congress 👉 Register here: oncodaily.com/lungo-2026-vir…
3
81
Cassio Murilo T. Hidalgo Filho retweeted
Meet our LungÕ 2026 speaker: Cassio Murilo Hidalgo Filho! We’re delighted to welcome Dr. Cassio Murilo Hidalgo Filho (@CMHidalgoFilho), Medical Oncologist and Postdoctoral Fellow in Thoracic Oncology at Dana-Farber Cancer Institute, Harvard Medical School, USA, to LungÕ 2026 – Virtual Global Congress on Lung Oncology. Join us for a global exchange of ideas on advancing lung cancer care. 📅 November 5, 2026 🌐 Virtual congress 👉 Register here: oncodaily.com/lungo-2026-vir…
1
1
1
174
Honored to bring an early-career voice to Lung Cancer Considered, the official IASLC podcast, sharing perspectives on #WCLC26 and the IASLC Academy! Thank you, @NarjustFlorezMD , for the opportunity!
#EarlyCareer Takeover! Drs. Sara Fra, @CMHidalgoFilho & Nan Sethakorn share their #WCLC26 experiences, from the latest research and global networking to mentorship, grants & #careerdevelopment opportunities through the IASLC Academy. 🎧 Listen now: bit.ly/4rXwFYx #LungCancerConsidered #ThoracicOncology
2
9
590
Cassio Murilo T. Hidalgo Filho retweeted
🎙️ New #LungCancerConsidered! In a special #Nurse Practitioner takeover from #WCLC26, Laura Macke, Stephanie McDonald & @MaryPasquinelli discuss key developments in small cell lung cancer, ADCs & #lungcancer #screening, and what APPs can take back to the clinic. 🎧 bit.ly/47ri6my #ThoracicOncology #Oncology
5
2
13
1,382
Cassio Murilo T. Hidalgo Filho retweeted
Wrapping Up an Inspiring WCLC26 in Seoul - Cassio Murilo Hidalgo Filho (@CMHidalgoFilho) oncodaily.com/voices/cassio-…
1
1
214
Results of AMIGO-1 (LACOG 0821), a phase II trial of amivantamab + lazertinib + pemetrexed as 1st-line treatment for advanced EGFR-mutant NSCLC, presented at #WCLC26 by Dr. William Nassib William Junior. Primary endpoint met: 18-month PFS of 66.7% (median 25.1 months). #LACOG
8
1
17
631
Wrapping up an inspiring #WCLC26 in Seoul 🇰🇷 Two posters presented, a podcast recorded, the IASLC Academy Award workshop, and many outstanding projects from friends and collaborators. Grateful for the science, new connections, and the chance to experience Korean culture!
7
323
Cassio Murilo T. Hidalgo Filho retweeted
Cassio Murilo Hidalgo Filho Receives IASLC Academy Award in Seoul @CMHidalgoFilho oncodaily.com/voices/cassio-…
1
3
248
Grateful for the incredible mentors who have been guiding me throughout my journey! @BRicciutiMD @JuliaRotow
Congratulations to @DiFedericoMD on receiving the @IASLC Educational Award and to @CMHidalgoFilho on being selected for the @IASLC Academy! Very well deserved. Even more exciting to see them both presenting our work on #BRAF class II/III alterations and #STK11/#KEAP1 in RAS-dependent NSCLC at #WCLC26. #LCSM @ChristianRolfo @g_mountzios @marinagarassino @DanaFarberNews @BalazsHalmosMD @NarjustFlorezMD
1
13
1,108
Cassio Murilo T. Hidalgo Filho retweeted
GBOT no WCLC 2026!
2
4
212
Cassio Murilo T. Hidalgo Filho retweeted
Very happy to have had the opportunity to participate in the @IASLC Academy this year. An inspiring experience connecting with colleagues and mentors, gaining valuable insights for my project and my journey in oncology. Grateful for the opportunity to learn and exchange ideas! – at Gangnam-gu, Republic of Korea
2
13
464
Cassio Murilo T. Hidalgo Filho retweeted
🇧🇷 mentees at the @IASLC Academy Program and @ClaudioVladmir. #WCLC26. @GBOT_Alerta @CMHidalgoFilho @AlineFaresMD – at Gangnam-gu, Republic of Korea
3
9
218
Honored to be selected as a recipient of the @IASLC Academy Award - a global award recognizing early-career physicians in thoracic oncology. 🫁 A special thanks to the chairs Dr. @JairBar4 and @ZPiotrowskaMD and my mentor @BalazsHalmosMD for this great experience!
3
3
32
1,358
Thank you @GBOT_Alerta !! Glad to represent our country 🇧🇷 with brilliant friends! @leogilsan and @AlineFaresMD
Parabéns Aline Fares, Leonardo Santana e Murilo Hidalgo!
4
204
Cassio Murilo T. Hidalgo Filho retweeted
Never underestimate the power of a hallway conversation. Today’s quick exchange can become tomorrow’s collaboration, study, and breakthrough. This is where ideas connect and possibilities begin. #WCLC26
9
32
1,568
Cassio Murilo T. Hidalgo Filho retweeted
👏 Leonardo Brunetti has been selected as the recipient of the inaugural ESMO #ArtificialIntelligence (#AI) Fellowship. Supporting AI-driven solutions that bridge data science and patient care. 🔗 ow.ly/mifV50ZIxVH #ESMOFellowships
3
2
15
3,335
Next week, I’ll present two studies at #WCLC26 in Seoul! 🇰🇷 Our main work explores how STK11/KEAP1 shape outcomes across genomic contexts in RAS-activated KRAS-WT NSCLC. I’ll also share Brazilian real-world data on KRAS/STK11. Grateful to my mentors and collaborators!
1
2
14
279
Cassio Murilo T. Hidalgo Filho retweeted
Tumor Mutational Burden May Serve as a Dual-Purpose Biomarker - Federica Pecci @pecci_federica1
1
3
9
270
Cassio Murilo T. Hidalgo Filho retweeted
Getting late to this review on resistance to ICIs in NSCLC by @CMHidalgoFilho and @BRicciutiMD at @JCO_ASCO. Take: This is one of the biggest challenges in NSCLC (Fig2). After resistance to ICIs, treatments become toxic and less effective. This is NOT one size fits all (Fig3). We will require multiple solutions for complex mechanisms of resistance. I see STK11/KEAP1 comutation subgroup as one of the biggest challenges and TGF B as a promising candidate. #NSCLC #ImmunoOncology #LCSM
4
17
1
53
10,526